William C. Hicks, a Member in the Corporate & Securities Section of Mintz. Levin, Cohn, Ferris, Glovsky and Popeo, P.C., will be the moderator of a panel discussion at the 15th annual BIO CEO & Investor Conference. The conference is being held February 12-15 in New York.
Mr. Hicks will be moderating a discussion entitled, “The Road Less Traveled: Alternative Avenues to Public Markets.” The discussion will focus on the increasing number of companies that have employed alternate routes to the public markets, using reverse mergers, Form-10 self-filings, and variations of each to avoid the expense, uncertainty and complexity of the IPO process. The panelists include:
• Charles Crain, Manager, Policy & Research, BIO
• Michelle Dipp, MD, PhD, Chief Executive Officer & Co-Founder, OvaScience
• Daniel B. Dubin, MD, Vice Chairman, Chief Knowledge Officer & Founder of MEDACorp, Leerink Swann
• Peter Kolchinsky, PhD, Managing Partner, RA Capital
The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies.